Juvenile idiopathic arthritis-associated uveitis (original) (raw)

2010, Current Opinion in Ophthalmology

Purpose of Review-To describe recent evidence from the literature pertaining to juvenile idiopathic arthritis (JIA) associated uveitis. Recent Findings-Uveitis is most common in extended oligoarticular JIA. A significant number of patients already have ocular complications at time of diagnosis of uveitis. Risk factors for complications include either abnormally high or low intraocular pressure, posterior synechiae, male gender, temporal proximity to diagnosis of arthritis and topical corticosteroid use. Use of immunosuppressive agents significantly reduces ocular complications. Aggressive peri-operative control of intraocular inflammation is necessary for successful cataract surgery with lens implantation. Controlled clinical trials are under way to assess the efficacy of biologic agents in JIA-associated uveitis. Long term safety, however, is still unknown. Summary-JIA-associated uveitis carries significant ocular morbidity that lasts well into adulthood. Treatment with immunosuppressive agents can reduce the risk of ocular complications. Biologics hold promise in the treatment of JIA-associated uveitis but require long-term data to assess their safety.

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact